Interestingly, a recent genome-wide CRISPR-Cas9 screen, carried out by incubating EHEC with human colorectal carcinoma cell line HT-29, also identified LAPTM4A and TM9SF2 as key factors for EHEC toxicity to cells [34]. This evidence concerns the gene LAPTM4A and colorectal carcinoma.